2020, Number 2
<< Back Next >>
Rev Cub de Reu 2020; 22 (2)
Recurrent polychondritis. Clinical, diagnosis and treatment
Ucinia BLP, Viteri TFJ, Peralvo SSP, Peralvo SMF, Peralvo SJA
Language: Spanish
References: 37
Page: 1-14
PDF size: 303.87 Kb.
ABSTRACT
Recurrent polychondritis is a rare condition characterized by recurrent inflammation of cartilage and other tissues throughout the body. Ear involvement is the most common feature, but a variety of other areas of the body may be compromised, including costal cartilage, eyes, nose, airways, heart, vascular system, skin, joints, kidneys and nervous system. The signs and symptoms vary from person to person depending on the body parts affected. The exact underlying cause of recurrent polychondritis is unknown; however, scientists suspect it is an autoimmune condition. The main goals of treatment for people with recurrent polychondritis are to alleviate current symptoms and preserve the structure of the affected cartilage.
REFERENCES
Puéchal X, Terrier B, Mouthon L, Costedoat-Chalumeau N, Guillevin L, Le Jeunne C. Relapsing polychondritis. Joint Bone Spine. 2014 Mar;81(2):118-24.
Borgia F, Giuffrida R, Guarneri F, Cannavò SP. Relapsing polychondritis: An updated review. Biomedicines. 2018 [Acceso 16/02/2020];6(3):84. Disponible en: https://www.mdpi.com/2227-9059/6/3/84/pdf
Jaksch-Wartenhorst R. Polychondropathia. Wiener Archiv für Inn Med. 1923;6:93-4.
Ebringer R, Rook G, Swana GT, Bottazzo GF, Doniach D. Autoantibodies to cartilage and type II collagen in relapsing polychondritis and other rheumatic diseases. Ann Rheum Dis. 1981;40:473-9.
Arundell FW, Haserick JR. Familial chronic atrophic polychondritis. Arch Dermatol. 1960;82:353-65.
Alexandros A. Drosos. Relapsing polychondritis. Orphanet Encyclopedia. 2004 Oct [Acceso 16/02/2020]. Disponible en: http://www.orpha.net/data/patho/GB/uk-RP.pdf
Neilly JB, Winter JH, Stevenson RD. Progressive tracheobronchial polychondritis: need for early diagnosis. Thorax. 1985;40:78-9.
Jain TK, Sood A, Sharma A, Basher RK, Bhattacharya A, Mittal BR. Response assessment in relapsing polychondritis with 18F-FDG PET/CT. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition). 2017;2(36):124-5.
Vargas P, Loyola K, Schrag B, Solís S. Policondritis recidivante. Revista Argentina de Dermatología. 2016;97(2):84-9.
Longo L, Greco A, Rea A, Lo Vasco VR, De Virgilio A, De Vincentiis. Relapsing polychondritis: A clinical update. Autoimmun Rev. 2016 [Acceso 16/02/2020];15(6):539-43. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S1568997216300398
Caballero M, Mimbela I. Policondritis Recidivante. Revista Peruana de Reumatología. 2019;25(2):28-9.
Lee JE, Lee EK. A case of membranous nephropathy associated with relapsing polychondritis. Kidney Res Clin Pract. 2012;31:253-6.
Gorospe L, Barrios D, Criado IS, de la Puente Bujidos C. Diagnóstico de policondritis recidivante en una paciente con tos crónica y sin condritis nasal ni auricular. Reumatología Clínica. 2019;15(5):51-2.
Díaz Pérez AL, Mendoza LCC, Carvajal DÁ, Valladares CJC. (2016). Policondritis recidivante. Informe de un caso. 16 de Abril. 2016 [Acceso 16/02/2020];54(260):69-74. Disponible en: http://www.rev16deabril.sld.cu/index.php/16_04/article/view/358
Michon A, Arlet J B, Pouchot J. (2016). Policondritis recidivante. EMC-Aparato Locomotor. 2016 [Acceso 21/02/2020];49(3):1-9. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S1286935X16791398
Lisanti R, Gatica D, Abal J, Di Giorgi L. (2015). Policondritis recidivante, un desafío diagnóstico. Revista americana de medicina respiratoria. 2015;15(2):146-9.
Quenard, M I, García Carrasco M, Ramos Casals M. (2001). Policondritis recidivante. Med Integral. 2001:25-9.
Meza Junco J, Remes Troche JM, Montaño Loza A. Policondritis recidivante: presentación de 5 casos, revisión de la literatura. Rev Mex Reumatol. 2001;6(5):309-14.
Bellamy N, Dewar CL. Relapsing polychondritis in pregnancy. J Rheumatol. 1990;17:1525-6.
Sallam A, Islam T, Parmar DN. Keratouveitis as a first presentation of relapsing polychondritis. Case Rep Med. 2010 [Acceso 21/02/2020]:176514. Disponible en: http://downloads.hindawi.com/journals/crim/2010/176514.pdf
Starr JC, Taneja N, Brasher GW. Relapsing polychondritis following alopecia areata. Case Rep Med. 2010 [Acceso 16/02/2020]:623158. Disponible en: http://downloads.hindawi.com/journals/crim/2010/623158.pdf
Erten-Lyons D, Oken B, Woltjer R, Quinnn J. Relapsing polychondritis: an uncommon cause of dementia. BMJ. 2009 May [Acceso 21/02/2020];79(5):609-10. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3100775/
Kim MK, Park KS, Min JK, Cho CS, Kim HY. A case of polychondritis in a patient with Behçet´s disease. Korean J Intern Med. 2005 [Acceso 18/02/2020];20:339-42. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3891082/
Bochtler T, Hensel M, Lorenz HM, Ho AD, Mahlknecht U. Chronic lymphocytic leukaemia and concomitant relapsing polychondritis: A report on one treatment for the combined manifestation of two diseases. Rheumatology (Oxford). 2005 [Acceso 16/02/2020];44(9):1199. Disponible en: https://academic.oup.com/rheumatology/article-pdf/44/9/1199/14117867/keh670.pdf
Duda J, Botka M. Unusual case of relapsing polychondritis. Rheumatology. 2001;15:136.
McAdam L, Lawrence P, O'Hanlan MA, Bluestone R, Pearson C. Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine (Baltimore). 1976 [Acceso 12/02/2020];55:193-215. Disponible en: https://journals.lww.com/md-journal/citation/1976/05000/relapsing_polychondritis__prospective_study_of_23.1.aspx
Damiani JM, Levine HL. Relapsing polychondritis -report of ten cases. Laryngoscope. 1979;89:929-46.
Silvariño R, Vola ME, Schimchak P, Cairoli E, Alonso J. Policondritis recidivante: presentación clínica, diagnóstico y tratamiento. Revista Médica del Uruguay. 2009 [Acceso 16/02/2020];25(3):168-72. Disponible en: http://www.scielo.edu.uy/scielo.php?script=sci_arttext&pid=S1688-03902009000300005
Van der Lubbe PA, Miltenburg AM, Breedveld FC. Anti-CD4 monoclonal antibody for relapsing polychondritis. Lancet. 1991 [Acceso 16/02/2020];337(8753):1349. Disponible en: https://www.thelancet.com/journals/lancet/article/PII0140-6736(91)93023-3/fulltext
Handler RP. Leflunomide for relapsing polychondritis: successful longterm teatment. J Rheumatol. 2006 [Acceso 23/02/2020];33(9):1916. Disponible en: http://www.jrheum.org/content/jrheum/33/9/1916.full-text.pdf
Pallo PA O, Levy-Neto M, Pereira RMR, Shinjo SK. (2017). Policondrite recidivante: prevalência de doenças cardiovasculares e seus fatores de risco e características gerais da doença de acordo com o gênero. Revista Brasileira de Reumatologia. 2017 [Acceso 16/02/2020];57(4):338-45. Disponible en: https://www.scielo.br/scielo.php?pid=S0482-50042017000400338&script=sci_arttext&tlng=pt
Koenig AS, Abruzzo JL. Leflunomide induced fevers, thrombocytosis and leukocytosis in a patient with relapsing polychondritis. J Rheumatol. 2002 [Acceso 16/02/2020];29:192-4. Disponible en: http://www.jrheum.org/content/29/1/192.short
Ehresmann GR. Infliximab in the treatment of polychondritis. ACR Poster Session A. Pathogenesis and treatment of rare rheumatic diseases II. Rheumatology. 2002;46:1738-9.
de Barros AP, Nakamura NA, Santana T de F, Motta JQ, Bianchi WA. Infliximab in relapsing polychondritis. Rev Bras Reumatol. 2010 [Acceso 16/02/2020];50:211-16. Disponible en: https://core.ac.uk/download/pdf/188932180.pdf
Carter JD. Treatment of relapsing polychondritis with a TNF antagonist. J Rheumatol. 2005 [Acceso 16/02/2020];32(7):1413. Disponible en: http://www.jrheum.org/content/jrheum/32/7/1413.full-text.pdf
Seymour MW, Home DM, Wiliams RO, Allard SA. Prolonged response to anti-tumour necrosis factor treatment with adalimumab (Humira) in relapsing polychondritis complicated by aortitis. Rheumatology. 2007 [Acceso 16/02/2020];46(11):1738-9. Disponible en: https://academic.oup.com/rheumatology/article-pdf/46/11/1738/5052170/kem229.pdf
Rovenský J, Sedláčková M. Relapsing Polychondritis. J Rheum Dis Treat. 2016 [Acceso 16/02/2020];2:043. Disponible en: https://clinmedjournals.org/articles/jrdt/journal-of-rheumatic-diseases-and-treatment-jrdt-2-043.pdf